Fig. 11From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluationCompartmental analysis by Pk Solver showed the pharmacokinetic and bioavailability profile of nanoformulations of VC-loaded TCs-HA compared to the marketed injection of vincristineBack to article page